Study identifies dose threshold for omega-3’s heart benefits

By Stephen Daniells

- Last updated on GMT

250 mg may be the threshold for EPA/DHA benefits...
250 mg may be the threshold for EPA/DHA benefits...
Daily doses of omega-3s of at least 250 milligrams are required to reduce the risk of sudden cardiac death and other heart conditions, says a new review and meta-analysis.

According to findings published in the British Journal of Nutrition​, at least 250 mg of the long-chain omega-3 fatty acids (LCFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), was associated with a 35 percent reduction in the risk of sudden cardiac death.

In addition, such doses were associated with a ‘near-significant’ 17 percent decrease in the risk of ‘total fatal coronary events’, according to a team of researchers from academia and industry.

“Thus, the intake of 250 mg omega-3 LCFA per day may, indeed, be a minimum target to be achieved by the general population for the promotion of cardiovascular health,”​ wrote authors led by Kathy Musa-Veloso from Cantox Health Sciences International.

The study’s authors were affiliated with Cantox, the University of Toronto, the Global Organization for EPA and DHA Omega-3s (GOED), Denomega Nutritional Oils AS, Ocean Nutrition Canada, and Monsanto.

Current recommendations

The European Food Safety Authority (EFSA) concluded in 2009 that 250mg should be the labeling reference intake value for long-chain omega-3 fatty acids.

In the US, the recently released 2010 Dietary Guidelines for Americans did not include specific EPA/DHA recommendations, but instead recommended consumption levels of seafood of 8-12 ounces per week, “which provide an average consumption of 250 mg per day of EPA and DHA”​.

The new meta-analysis and review sought to test such recommendations. The reviewers identified 8 prospective studies to include, and these indicated that consuming at least 250 mg was associated with a significant reduction in sudden cardiac death and near-significant reductions in the risk of total fatal coronary events.

“In several meta-analyses, which were based on US studies, risk of [coronary heart disease] death was found to be dose-dependently reduced by the omega-3 LCFA, with further risk reductions observed with intakes in excess of 250 mg/d,”​ they added.

Minimum, not optimum

Co-author of the paper, Harry Rice, PhD, VP of regulatory & scientific affairs for GOED, told NutraIngredients-USA that the results “suggest that 250mg/day EPA+DHA should beconsidered a minimum, not an optimum, level of consumption.

“What is really novel about this meta-analysis is that the data used were from subjects previously free of known coronary heart disease; thus, the positive results provide further evidence of the need for establishing a dietary reference intake (DRI) for the long-chain omega-3 fatty acids.

“Study after study, the cardioprotective benefits of EPA and DHA are demonstrated. In the interest of public health, the Institute of Medicine (IOM) should assess the current data on health outcomes associated with the long-chain omega-3s.

“GOED is confident that the evidence would support a cardioprotective role for EPA and DHA,”​ he added.

Source: British Journal of Nutrition
Published online ahead of print, FirstView Articles, doi: 10.1017/S0007114511001644
“Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease”
Authors: K. Musa-Veloso, M.A. Binns, A. Kocenas, C. Chung, H. Rice, H. Oppedal-Olsen, H. Lloyd, S. Lemke

Related news

Show more

Related products

show more

Comprehensive Nutritional Lipid Solutions

Comprehensive Nutritional Lipid Solutions

Content provided by INNOBIO Corporation Limited | 24-Sep-2024 | White Paper

INNOBIO specializes in high-quality DurOmega® functional lipid products, emphasizing enhanced fatty acid quality and application performance.

Dynamic Duo - More Power, Less Fatigue

Dynamic Duo - More Power, Less Fatigue

Content provided by Enovate Biolife LLC | 27-Jun-2024 | White Paper

Better physical performance & vitality have deep connections to muscular as well as cardio-respiratory health.

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 08-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Related suppliers

Follow us

Products

View more

Webinars